Eris sublineage EG.5.1 can escape neutralizing antibodies better than other SARS-CoV-2 lineages

As a result of vaccination or infection, our immune system produces antibodies that attach to the spike protein of SARS-CoV-2, preventing the virus from entering and replicating within cells.

Congress nears deal to rein in PBMs after years of debate

WASHINGTON — After two years of haggling, Congress has nearly reached a deal to rein in the drug-industry middlemen known as pharmacy benefit managers. Lawmakers

December 17, 2024

FDA lifts partial hold on Phase III plans for rare ataxia drug – Pharmaceutical Technology

The company plans to enrol patients into the Phase III NEAT study in Q2 2024. Credit: Billion Photos via www.shutterstock.com Quince Therapeutics has announced that

October 2, 2023

Climate change to slash seafood nutrients by 30% in low-income countries

The nutrients available from seafood could drop by 30 per cent for low-income countries by the end of the century due to climate change, suggests

October 31, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.